ELISA Analyzers

Global ELISA Analyzers Market to Reach US$1.3 Billion by 2030

The global market for ELISA Analyzers estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 2.1% over the analysis period 2024-2030. Optical Filter ELISA Analyzer, one of the segments analyzed in the report, is expected to record a 1.6% CAGR and reach US$869.0 Million by the end of the analysis period. Growth in the Optical Grating ELISA Analyzers segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$322.9 Million While China is Forecast to Grow at 4.1% CAGR

The ELISA Analyzers market in the U.S. is estimated at US$322.9 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$253.3 Million by the year 2030 trailing a CAGR of 4.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.8% and 1.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.1% CAGR.

Global ELISA Analyzers Market – Key Trends & Drivers Summarized

What Are ELISA Analyzers, and Why Are They Essential in Diagnostics?

Enzyme-Linked Immunosorbent Assay (ELISA) analyzers are laboratory instruments used to detect and quantify biological substances such as proteins, hormones, antibodies, and antigens. These analyzers play a crucial role in clinical diagnostics, pharmaceutical research, and food safety testing, offering high sensitivity and specificity in disease detection and biomarker analysis. ELISA analyzers are widely utilized in hospitals, diagnostic laboratories, research institutions, and biotechnology firms for applications ranging from infectious disease screening to oncology diagnostics. The growing prevalence of autoimmune diseases, cancer, and infectious diseases such as HIV, hepatitis, and COVID-19 has driven the demand for high-throughput ELISA testing, leading to advancements in automation, multiplexing, and real-time analysis. Additionally, the increasing focus on personalized medicine and early disease detection has expanded the adoption of ELISA technology in precision diagnostics.

How Are Technological Advancements Enhancing ELISA Analyzer Capabilities?

The ELISA analyzers market has witnessed significant technological progress, particularly in automation, assay sensitivity, and integration with data management systems. The development of fully automated ELISA analyzers has streamlined workflow efficiency, reducing human errors and improving turnaround times in clinical laboratories. Multiplex ELISA platforms, which allow for simultaneous detection of multiple analytes in a single sample, have gained popularity in biomarker research and clinical diagnostics. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) in ELISA data interpretation has enhanced result accuracy and reproducibility, enabling faster and more precise diagnostics. The emergence of portable and point-of-care ELISA devices has also expanded market reach, particularly in resource-limited settings where rapid diagnostic solutions are essential. Additionally, advancements in microfluidics and nanotechnology have led to the development of miniaturized ELISA systems, offering enhanced sensitivity and cost-effective solutions for large-scale screening programs.

Which Industries and Applications Are Driving ELISA Analyzer Demand?

The healthcare and pharmaceutical sectors remain the primary drivers of ELISA analyzer demand, with widespread applications in clinical diagnostics, vaccine development, and therapeutic drug monitoring. The increasing prevalence of chronic and infectious diseases has fueled the need for ELISA-based diagnostic tests in hospitals and reference laboratories. Additionally, ELISA analyzers are extensively used in pharmaceutical and biotechnology research for drug discovery, immunogenicity testing, and clinical trial monitoring. The food and beverage industry also represents a significant market, as ELISA-based assays are crucial for detecting foodborne pathogens, allergens, and contaminants such as pesticides and mycotoxins. Veterinary diagnostics is another growing segment, with ELISA tests playing a vital role in monitoring livestock diseases and ensuring food safety. The rising adoption of ELISA analyzers in academic research institutions for immunology and proteomics studies further contributes to market growth.

What Is Driving the Growth of the ELISA Analyzers Market?

The growth in the ELISA analyzers market is driven by several factors, including the increasing burden of infectious and chronic diseases, rising demand for high-throughput diagnostic solutions, and technological advancements in assay automation and multiplexing. The global expansion of healthcare infrastructure and the growing emphasis on preventive diagnostics have boosted ELISA adoption in both developed and emerging economies. The ongoing shift toward personalized medicine has also increased demand for biomarker-based ELISA testing, facilitating early disease detection and targeted therapies. Moreover, the expanding applications of ELISA in food safety, veterinary diagnostics, and environmental monitoring have diversified market opportunities. The introduction of cost-effective and portable ELISA systems has further enhanced accessibility, particularly in remote and underserved regions. Additionally, regulatory initiatives promoting quality assurance in diagnostic testing have reinforced market growth, driving investments in advanced ELISA technologies and laboratory automation.

SCOPE OF STUDY:

The report analyzes the ELISA Analyzers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type Scope (Optical Filter ELISA Analyzer, Optical Grating ELISA Analyzers); Mode Scope (Automated ELISA Analyzers, Semi-Automated ELISA Analyzers); Application (Immunology, Vaccine development, Drug Monitoring, Others); End-User Scope (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Diagnostic Laboratories)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

• Agilent Technologies, Inc.
• Autobio Diagnostics Co., Ltd.
• Awareness Technology, Inc.
• Beckman Coulter Life Sciences
• Berthold Technologies GmbH & Co. KG
• BIOLINE Medical Systems
• Danaher Corporation
• Dynex Technologies, Inc.
• Enzo Life Sciences, Inc.
• Eurofins Scientific
• F. Hoffmann-La Roche Ltd.
• Gold Standard Diagnostics Corp.
• Grifols, S.A.
• Hamilton Company
• Mindray Medical International Ltd.
• PerkinElmer, Inc.
• R&D Systems, Inc.
• Rayto Life and Analytical Sciences Co., Ltd.
• Shenzhen New Industries Biomedical Engineering Co., Ltd. (Snibe)
• Siemens Healthineers

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.